Related Experiment Videos

[Ischemic hepatitis]

J Muszyński1, A Ehrmann-Jóśko, J Stanisławska-Nielepkiewicz

  • 1Kliniki Gastroenterołogii i Chorób Przemiany Materii Akademii Medycznej w Warszawie.

Insights

Patients with severe heart failure can experience ischemic hepatitis, a condition marked by liver cell damage indicated by elevated liver enzymes. Recovery of liver function is linked to the improvement of the underlying heart condition.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Congestive heart failure (CHF) can lead to reduced liver perfusion.
  • Acute deterioration of CHF, such as pulmonary edema and hypotension, exacerbates liver hypoperfusion.
  • This hypoperfusion can result in acute liver cell damage, termed ischemic hepatitis.

Observation:

  • Patients with acute heart failure exacerbations exhibit signs of ischemic hepatitis.
  • Key indicators include significantly elevated aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) levels.
  • Slight increases in bilirubin, alkaline phosphatase, and glucose may also be observed, with no evidence of viral hepatitis.

Findings:

  • A case study detailed a 34-year-old male with a history of myocardial infarction and CHF, admitted in shock.
  • Despite no acute myocardial infarction signs on ECG/Echo, he presented with severe liver cell damage (very high AST, ALT, LDH).
  • Diagnosis was ischemic hepatitis, with liver function normalizing upon heart failure improvement.

Implications:

  • Ischemic hepatitis in CHF patients is a reversible condition.
  • Prognosis for ischemic hepatitis is directly dependent on the management and course of the underlying heart failure.
  • This highlights the critical interplay between cardiac function and liver health.

Related Concept Videos